SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-21-034589
Filing Date
2021-06-25
Accepted
2021-06-25 16:14:05
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 srne-s3.htm S-3 420682
2 EX-5.1 srne-ex51_98.htm EX-5.1 24558
3 EX-23.1 srne-ex231_27.htm EX-23.1 2712
4 EX-23.2 srne-ex232_26.htm EX-23.2 2749
5 GRAPHIC gmj5daceufuj000002.jpg GRAPHIC 17892
6 GRAPHIC gt3ezrahq5oq000001.jpg GRAPHIC 3210
7 GRAPHIC gmj5daceufuj000001.jpg GRAPHIC 11200
8 GRAPHIC gt3ezrahq5oq000002.jpg GRAPHIC 3210
  Complete submission text file 0001564590-21-034589.txt   501287
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-257412 | Film No.: 211047847
SIC: 2836 Biological Products, (No Diagnostic Substances)